A206640 Stock Overview
Boditech Med Inc. develops products for in-vitro diagnostics and diagnostic reagents.
Boditech Med Competitors
Price History & Performance
|Historical stock prices|
|Current Share Price||₩13,900.00|
|52 Week High||₩26,800.00|
|52 Week Low||₩13,600.00|
|1 Month Change||-10.32%|
|3 Month Change||-6.71%|
|1 Year Change||-28.54%|
|3 Year Change||25.79%|
|5 Year Change||-27.79%|
|Change since IPO||-75.02%|
Recent News & Updates
Boditech Med Inc. (KOSDAQ:206640) Shares Fly 49% But Investors Aren't Buying For Growth
Boditech Med Inc. ( KOSDAQ:206640 ) shares have had a really impressive month, gaining 49% after a shaky period...
|A206640||KR Medical Equipment||KR Market|
Return vs Industry: A206640 underperformed the KR Medical Equipment industry which returned -4.7% over the past year.
Return vs Market: A206640 underperformed the KR Market which returned -14.3% over the past year.
|A206640 Average Weekly Movement||6.4%|
|Medical Equipment Industry Average Movement||5.6%|
|Market Average Movement||5.4%|
|10% most volatile stocks in KR Market||10.2%|
|10% least volatile stocks in KR Market||3.1%|
Stable Share Price: A206640 is not significantly more volatile than the rest of KR stocks over the past 3 months, typically moving +/- 6% a week.
Volatility Over Time: A206640's weekly volatility (6%) has been stable over the past year.
About the Company
Boditech Med Inc. develops products for in-vitro diagnostics and diagnostic reagents. It offers ichroma II, an automatic or semiautomatic in-vitro diagnostic device that measures the concentration of analytes, contained in blood, urine, or other samples, in quantitative, or semi-quantitative ways; automated fluorescent immunoassay systems under AFIAS-6 and AFIAS-1 names that uses blood, urine, and other samples to measure quantitatively or semi-quantitatively the concentration of targeted analytes; ichroma-50, an automatic immunoassay analyzer that measures the concentration of targeted analytes in body fluids, such as blood, urine, and other samples; and ichroma M2, a portable analyzer intended to be used with in vitro diagnostic immunofluorescent assay kits for screening, monitoring and/or examining routine physics in centralized laboratories of hospitals or physician’s clinics. The company also provides Ichroma TRIAS Reader, an in vitro diagnostic device that measures the concentration of targeted analyte from various samples, such as blood, nasal swabs, and nasopharyngeal swabs; Hemochroma PLUS, an in vitro diagnostic device to quantitative test total hemoglobin concentration in the blood; i-chamber, an auxiliary device for the ichroma systems; and HandyRay, a laser device for the capillary blood sampling without a needle.
Boditech Med Fundamentals Summary
|A206640 fundamental statistics|
Is A206640 overvalued?See Fair Value and valuation analysis
Earnings & Revenue
|A206640 income statement (TTM)|
|Cost of Revenue||₩59.52b|
Last Reported Earnings
Dec 31, 2021
Next Earnings Date
|Earnings per share (EPS)||1.96k|
|Net Profit Margin||28.13%|
How did A206640 perform over the long term?See historical performance and comparison
1.4%Current Dividend Yield
Is Boditech Med undervalued compared to its fair value and its price relative to the market?
Valuation Score 5/6
Below Fair Value
Significantly Below Fair Value
PE vs Industry
PE vs Market
PB vs Industry
Undervalued compared to fair value
Share Price vs. Fair Value
Below Fair Value: A206640 (₩13900) is trading below our estimate of fair value (₩47586.89)
Significantly Below Fair Value: A206640 is trading below fair value by more than 20%.
Price To Earnings Ratio
PE vs Industry: A206640 is good value based on its Price-To-Earnings Ratio (7.1x) compared to the KR Medical Equipment industry average (13.6x).
PE vs Market: A206640 is good value based on its Price-To-Earnings Ratio (7.1x) compared to the KR market (14.1x).
Price to Earnings Growth Ratio
PEG Ratio: Insufficient data to calculate A206640's PEG Ratio to determine if it is good value.
Price to Book Ratio
PB vs Industry: A206640 is good value based on its Price-To-Book Ratio (2.1x) compared to the KR Medical Equipment industry average (2.4x).
How is Boditech Med forecast to perform in the next 1 to 3 years based on estimates from 0 analysts?
Future Growth Score0/6
Future Growth Score 0/6
Earnings vs Savings Rate
Earnings vs Market
High Growth Earnings
Revenue vs Market
High Growth Revenue
Forecasted Healthcare industry annual growth in earnings
In this section we usually present revenue and earnings growth projections based on the consensus estimates of professional analysts to help investors understand the company’s ability to generate profit. But as Boditech Med has not provided enough past data and has no analyst forecast, its future earnings cannot be reliably calculated by extrapolating past data or using analyst predictions.
This is quite a rare situation as 97% of companies covered by SimplyWall St do have past financial data.
How has Boditech Med performed over the past 5 years?
Past Performance Score3/6
Past Performance Score 3/6
Growing Profit Margin
Earnings vs Industry
Historical annual earnings growth
Earnings and Revenue History
Quality Earnings: A206640 has high quality earnings.
Growing Profit Margin: A206640's current net profit margins (28.1%) are lower than last year (31.6%).
Past Earnings Growth Analysis
Earnings Trend: A206640's earnings have grown significantly by 57.2% per year over the past 5 years.
Accelerating Growth: A206640's has had negative earnings growth over the past year, so it can't be compared to its 5-year average.
Earnings vs Industry: A206640 had negative earnings growth (-2.5%) over the past year, making it difficult to compare to the Medical Equipment industry average (15.1%).
Return on Equity
High ROE: A206640's Return on Equity (29.4%) is considered high.
How is Boditech Med's financial position?
Financial Health Score6/6
Financial Health Score 6/6
Short Term Liabilities
Long Term Liabilities
Financial Position Analysis
Short Term Liabilities: A206640's short term assets (₩131.1B) exceed its short term liabilities (₩27.1B).
Long Term Liabilities: A206640's short term assets (₩131.1B) exceed its long term liabilities (₩3.9B).
Debt to Equity History and Analysis
Debt Level: A206640 has more cash than its total debt.
Reducing Debt: A206640's debt to equity ratio has reduced from 3.5% to 3.2% over the past 5 years.
Debt Coverage: A206640's debt is well covered by operating cash flow (969.5%).
Interest Coverage: A206640 earns more interest than it pays, so coverage of interest payments is not a concern.
What is Boditech Med current dividend yield, its reliability and sustainability?
Dividend Score 2/6
Future Dividend Coverage
Current Dividend Yield
Dividend Yield vs Market
Notable Dividend: A206640's dividend (1.44%) is higher than the bottom 25% of dividend payers in the KR market (0.84%).
High Dividend: A206640's dividend (1.44%) is low compared to the top 25% of dividend payers in the KR market (2.75%).
Stability and Growth of Payments
Stable Dividend: Whilst dividend payments have been stable, A206640 has been paying a dividend for less than 10 years.
Growing Dividend: A206640's dividend payments have increased, but the company has only paid a dividend for 3 years.
Earnings Payout to Shareholders
Earnings Coverage: With its low payout ratio (10.3%), A206640's dividend payments are thoroughly covered by earnings.
Cash Payout to Shareholders
Cash Flow Coverage: With its low cash payout ratio (14.3%), A206640's dividend payments are thoroughly covered by cash flows.
Discover strong dividend paying companies
How experienced are the management team and are they aligned to shareholders interests?
Boditech Med has no CEO, or we have no data on them.
Who are the major shareholders and have insiders been buying or selling?
Insider Trading Volume
Insider Buying: Insufficient data to determine if insiders have bought more shares than they have sold in the past 3 months.
Dilution of Shares: Shareholders have not been meaningfully diluted in the past year.
Boditech Med Inc.'s employee growth, exchange listings and data sources
- Name: Boditech Med Inc.
- Ticker: A206640
- Exchange: KOSDAQ
- Founded: 1998
- Industry: Health Care Equipment
- Sector: Healthcare
- Implied Market Cap: ₩319.660b
- Shares outstanding: 22.59m
- Website: https://www.boditech.co.kr
Number of Employees
- Boditech Med Inc.
- 43, Geodudanji 1-gil
- South Korea
Company Analysis and Financial Data Status
|Data||Last Updated (UTC time)|
|Company Analysis||2022/05/24 00:00|
|End of Day Share Price||2022/05/24 00:00|
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.